نتائج البحث - "primary chemotherapy"

1

When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer

المؤلفون: Michael Friedlander, Anna deFazio, Christina M. Nagle, Andreas Obermair, Merran Williams, Kate Webber, Vanessa L. Beesley, Penelope M. Webb

المصدر: Gynecologic Oncology. 159:179-186

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Population, Anxiety, Patient Health Questionnaire, Severity of Illness Index, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Sleep Initiation and Maintenance Disorders, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Insomnia, Humans, Primary chemotherapy, Patient Reported Outcome Measures, Prospective Studies, education, Fatigue, Depression (differential diagnoses), Aged, Ovarian Neoplasms, Chemotherapy, education.field_of_study, Depression, business.industry, Age Factors, Obstetrics and Gynecology, Middle Aged, medicine.disease, Supportive interventions, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Quality of Life, Female, medicine.symptom, Ovarian cancer, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaf32f68d07818b04254199166232308Test
https://doi.org/10.1016/j.ygyno.2020.07.029Test

2

Original Radiotherapy after primary CHEMotherapy (RAPCHEM)

المؤلفون: J. Verloop, Adri C. Voogd, Paula H.M. Elkhuizen, Philip Poortmans, Liesbeth J. Boersma, A. Elise van Leeuwen, Ruud Houben, Sabine C. Linn, Ruud M. Pijnappel, Jelle Wesseling, Thijs van Dalen, Luc J. A. Strobbe, Linda de Munck

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, Epidemiologie

المصدر: Radiotherapy and Oncology, 145, 201-208. Elsevier Ireland Ltd

مصطلحات موضوعية: Oncology, medicine.medical_specialty, POSTMASTECTOMY RADIOTHERAPY, medicine.medical_treatment, Planning target volume, Breast Neoplasms, Systemic therapy, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, Breast cancer, Internal medicine, MASTECTOMY, medicine, Humans, Radiology, Nuclear Medicine and imaging, Primary chemotherapy, Prospective Studies, CANCER PATIENTS, LOCOREGIONAL RECURRENCE, Prospective cohort study, SURGICAL ADJUVANT BREAST, Neoplasm Staging, Netherlands, business.industry, INDIVIDUAL PATIENT DATA, INTERNAL MAMMARY, PREOPERATIVE CHEMOTHERAPY, Hematology, medicine.disease, Current analysis, Radiation therapy, Lymphatic Metastasis, 030220 oncology & carcinogenesis, AXILLARY DISSECTION, Radiotherapy, Adjuvant, business, Mastectomy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3869464fc6d9ef487ddd4f8d222ef1ceTest
https://doi.org/10.1016/j.radonc.2020.01.018Test

3

Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer

المساهمون: Institut Català de la Salut, [Schettini F] Translational Genomics and Targeted Therapies in Solid Tumors Research Group, Barcelona, Spain. Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. [Giuliano M] Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. [Lambertini M] Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. Department of Medical Oncology, U.O.C Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. [Bartsch R] Division of Oncology, Department of Medicine 1, Medical University of Vienna, Vienna, Austria. [Pinato DJ] Division of Cancer, Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK. Department of Translational Medicine, Università del Piemonte Orientale 'A. Avogadro', Novara, Italy. [Onesti CE] Clinical and Oncological Research Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy. [Cortes J] Oncology Department, IOB Institute of Oncology, Quiron Group, 08023 Madrid, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Schettini, Francesco, Giuliano, Mario, Lambertini, Matteo, Bartsch, Rupert, Pinato, David Jame, Onesti, Concetta Elisa, Harbeck, Nadia, Lüftner, Diana, Rottey, Sylvie, van Dam, Peter A, Zaman, Khalil, Mustacchi, Giorgio, Gligorov, Joseph, Awada, Ahmad, Campone, Mario, Wildiers, Han, Gennari, Alessandra, Tjan-Heijnen, Vivianne C G, Cortes, Javier, Locci, Mariavittoria, Paris, Ida, Del Mastro, Lucia, De Placido, Sabino, Martín, Miguel, Jerusalem, Guy, Venturini, Sergio, Curigliano, Giuseppe, Generali, Daniele, Schettini, F., Giuliano, M., Lambertini, M., Bartsch, R., Pinato, D. J., Onesti, C. E., Harbeck, N., Luftner, D., Rottey, S., van Dam, P. A., Zaman, K., Mustacchi, G., Gligorov, J., Awada, A., Campone, M., Wildiers, H., Gennari, A., Tjan-heijnen, V. C. G., Cortes, J., Locci, M., Paris, I., Mastro, L. D., De Placido, S., Martin, M., Jerusalem, G., Venturini, S., Curigliano, G., Generali, D.

المصدر: Cancers, Vol 13, Iss 4421, p 4421 (2021)
Scientia
CANCERS
Cancers
Cancers (Basel), 13 (17
E-Prints Complutense. Archivo Institucional de la UCM
instname
Università degli Studi del Piemonte Orientale-IRIS

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_treatment, Non‐pegylated liposomal doxorubicin, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], EPIRUBICIN, Review, Anthracycline, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Oncología, Breast cancer, CYCLOPHOSPHAMIDE, Medicine and Health Sciences, Endocrinología, Other subheadings::/therapeutic use [Other subheadings], NAB-PACLITAXEL, RC254-282, MULTICENTER TRIAL, anthracyclines, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], PRIMARY, TRASTUZUMAB PLUS DOCETAXEL, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Neoplasms. Tumors. Oncology. Including cancer and carcinogens, PHASE-III TRIAL, Sciences bio-médicales et agricoles, CHEMOTHERAPY, metastatic, Settore SECS-S/01 - STATISTICA, Metastatic, Epirubicin, medicine.drug, medicine.medical_specialty, Cyclophosphamide, Side effect, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], anthracycline, Hormone receptor, Quimioteràpia combinada, triple negative, Therapeutic index, breast cancer, Internal medicine, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], CONVENTIONAL DOXORUBICIN, medicine, Doxorubicin, Chemotherapy, Cardiotoxicity, business.industry, PRIMARY CHEMOTHERAPY, Otros calificadores::/uso terapéutico [Otros calificadores], ENCAPSULATED DOXORUBICIN, hormone receptor, medicine.disease, Anthracyclines, Triple negative, Cancérologie, Mama - Càncer - Tractament, Human medicine, 1ST-LINE THERAPY, business, non-pegylated liposomal doxorubicin